Trial Profile
Study of sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2016
Price :
$35
*
At a glance
- Drugs Metformin/sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 27 Jul 2016 New trial record
- 08 Jul 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics